Hereditary Angioedema in Swedish Adults: Report From the National Cohort.

Hereditary angioedema (HAE) is rare, disabling and sometimes life-threatening. The aim of this study is to describe its prevalence, symptomatology and treatment in Sweden. A total of 146 patients were identified; 110 adults and 36 children with HAE type I (n = 136) or II (n = 10), giving a minimal HAE prevalence of 1.54/100,000. All patients received a written questionnaire followed by a structured telephone interview. This report focuses on the 102 adults who responded. Females reported 19 attacks in the previous year vs. 9 for males (p < 0.01), and females reported 10 days of sick leave vs. 4 days for males (p < 0.05). For all treated acute attacks, plasma-derived C1-inhibitor concentrate (pdC1INH) (used in 27% of patients) had a good effect. For maintenance treatment, 43% used attenuated androgens and 8% used pdC1INH, which reduced their attack rate by more than 50%. In conclusion, the minimal HAE prevalence in Sweden was 1.54/100,000. HAE affected females more severely. Attenuated androgens and pdC1INH had a good effect on preventing attacks.

[1]  M. Triggiani,et al.  A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy , 2015, Orphanet Journal of Rare Diseases.

[2]  K. Beusterien,et al.  Socioeconomic burden of hereditary angioedema: results from the hereditary angioedema burden of illness study in Europe , 2014, Orphanet Journal of Rare Diseases.

[3]  A. Bygum.  Hereditary angioedema - consequences of a new treatment paradigm in Denmark. , 2014, Acta dermato-venereologica.

[4]  W. Kreuz,et al.  Characterization of prodromal symptoms in a large population of patients with hereditary angio‐oedema , 2014, Clincal and Experimental Dermatology.

[5]  H. Farkas,et al.  The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency , 2014, Orphanet Journal of Rare Diseases.

[6]  L. Mallbris,et al.  Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden. , 2014, Allergy and asthma proceedings.

[7]  A. Gompel,et al.  Hereditary angioedema in women: specific challenges. , 2013, Immunology and allergy clinics of North America.

[8]  M. Maurer,et al.  Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe , 2013, Allergy, Asthma & Clinical Immunology.

[9]  T. Craig,et al.  Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys. , 2013, Allergy and asthma proceedings.

[10]  D. Vasconcelos,et al.  Hereditary angioedema: first report of the Brazilian registry and challenges , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  R. Lockey,et al.  WAO Guideline for the Management of Hereditary Angioedema , 2012, The World Allergy Organization journal.

[12]  T. Machnig,et al.  Per-Attack Reporting of Prodromal Symptoms Concurrent with C1-Inhibitor Treatment of Hereditary Angioedema Attacks , 2012, Advances in Therapy.

[13]  M. Cicardi,et al.  Hereditary angio-oedema , 2012, The Lancet.

[14]  Tom Bowen,et al.  International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. , 2012, The Journal of allergy and clinical immunology.

[15]  M. Triggiani,et al.  Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.

[16]  S. Shyur,et al.  Type I hereditary angioedema in Taiwan -- clinical, biological features and genetic study. , 2011, Asian Pacific journal of allergy and immunology.

[17]  W. Lumry,et al.  The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. , 2010, Allergy and asthma proceedings.

[18]  K. Bork,et al.  Economic costs associated with acute attacks and long-term management of hereditary angioedema. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[19]  L. Juliano,et al.  The role of kinin B1 and B2 receptors in the scratching behaviour induced by proteinase‐activated receptor‐2 agonists in mice , 2010, British journal of pharmacology.

[20]  A. Bygum,et al.  Hereditary angio‐oedema in Denmark: a nationwide survey , 2009, The British journal of dermatology.

[21]  L. Mallbris,et al.  The establishment and utility of Sweha-Reg: a Swedish population-based registry to understand hereditary angioedema , 2007, BMC dermatology.

[22]  M. Schmelz,et al.  Bradykinin is a potent pruritogen in atopic dermatitis: A switch from pain to itch , 2006, Pain.

[23]  K. Bork.  Hereditary angioedema with normal C1 inhibitor activity including hereditary angioedema with coagulation factor XII gene mutations. , 2006, Immunology and allergy clinics of North America.

[24]  K. Bork,et al.  Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. , 2006, Biochemical and biophysical research communications.

[25]  A. Eckardt,et al.  Symptoms, Course, and Complications of Abdominal Attacks in Hereditary Angioedema Due to C1 Inhibitor Deficiency , 2006, The American Journal of Gastroenterology.

[26]  K. Bork,et al.  Hereditary angioedema: new findings concerning symptoms, affected organs, and course. , 2006, The American journal of medicine.

[27]  M. López-Trascasa,et al.  Hereditary angioedema due to C1 inhibitor deficiency: patient registry and approach to the prevalence in Spain. , 2005, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[28]  S. Choquet,et al.  Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema. , 2000, The Journal of allergy and clinical immunology.

[29]  K. Beusterien,et al.  The humanistic burden of hereditary angioedema: results from the Burden of Illness Study in Europe. , 2014, Allergy and Asthma Proceedings.

[30]  J. Bernstein.  HAE update: epidemiology and burden of disease. , 2013, Allergy and asthma proceedings.

[31]  Z. Ikezawa,et al.  [National prevalence survey of hereditary angioedema in Japan]. , 2011, Arerugi = [Allergy].

[32]  P. Keith,et al.  ALLERGY, ASTHMA & CLINICAL IMMUNOLOGY REVIEW Open Access , 2022 .